Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Amortizatization of Intangibles (2021 - 2023)

Historic Amortizatization of Intangibles for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $7.2 million.

  • ADC Therapeutics' Amortizatization of Intangibles fell 4134.96% to $7.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $19.2 million, marking a year-over-year increase of 5740.86%. This contributed to the annual value of $28.2 million for FY2024, which is 4694.64% up from last year.
  • Per ADC Therapeutics' latest filing, its Amortizatization of Intangibles stood at $7.2 million for Q4 2023, which was down 4134.96% from $6.7 million recorded in Q3 2023.
  • ADC Therapeutics' Amortizatization of Intangibles' 5-year high stood at $12.2 million during Q4 2022, with a 5-year trough of $268.0 in Q3 2019.
  • Its 5-year average for Amortizatization of Intangibles is $2.1 million, with a median of $395.0 in 2021.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first plummeted by 9986.75% in 2021, then skyrocketed by 315264005.17% in 2022.
  • Over the past 5 years, ADC Therapeutics' Amortizatization of Intangibles (Quarter) stood at $283.0 in 2019, then skyrocketed by 100960.07% to $286000.0 in 2020, then tumbled by 99.86% to $387.0 in 2021, then surged by 3152640.05% to $12.2 million in 2022, then tumbled by 41.35% to $7.2 million in 2023.
  • Its Amortizatization of Intangibles was $7.2 million in Q4 2023, compared to $6.7 million in Q3 2023 and $4.5 million in Q2 2023.